#HerantisPharma #phase1btrial #HER096 #Parkinsonsdisease #clinicaltrial #drugsafety #tolerability #pharmacokinetics #biomarkers #syntheticpeptidomimetic #cerebraldopamineneurotropicfactorprotein #CDNFprotein #MichaelJFoxFoundationforParkinsonsResearch #ParkinsonsUK
pharmatimes.com/news/heranti...
0
0
0
0